Want to see SG:C8R full AI Analyst Report?
Jiutian Chemical Group Limited (C8R) AI Stock Analysis
Jiutian Chemical Group Limited
(SGX:C8R)
The overall score is severely depressed by the company's operational distress, with collapsing revenues, deeply negative margins, and unsustainable cash burn. The balance sheet offers only a temporary buffer as equity rapidly erodes. Technicals confirm a persistent downtrend with no bullish reversal signals, and the negative P/E ratio underscores the lack of earnings power. The primary risk is continued financial deterioration without a clear turnaround catalyst.
Jiutian Chemical Group Limited (C8R) vs. iShares MSCI Singapore ETF (EWS)
- Market Cap
- SGD 29.83M
- Dividend Yield
- ―
- Average Volume (3M)
- 916.06K
- Price to Earnings (P/E)
- -0.6
- Beta (1Y)
- 1.45
- Revenue Growth
- -69.91%
- EPS Growth
- -13.56%
- Country
- Singapore
- Employees
- 200
- Sector
- Basic Materials
- Sector Strength
- 61
- Industry
- Chemicals
Jiutian Chemical Group Limited Business Overview & Revenue Model
Company Description
Jiutian Chemical Group Limited, established in Singapore in 1994, operates as an investment holding company with its primary chemical manufacturing and sales activities located in the People's Republic of China. The company's product portfolio encomp...
How the Company Makes Money
Jiutian Chemical Group Limited makes money primarily by manufacturing chemical products and selling them to industrial customers. Its revenue is mainly generated from (1) product sales: income from selling its manufactured chemical products, typicall...
Jiutian Chemical Group Limited Financial Statement Overview
Summary
Financial performance is critically weak. Revenue has collapsed to SGD 106M with deeply negative margins (gross -100%, net -155%). Operating and free cash flows are significantly negative, indicating unsustainable cash burn. The balance sheet provides a minor cushion with moderate leverage (D/E 0.28x), but equity is rapidly eroding due to persistent losses.
Income Statement
5Very NegativeBalance Sheet
25NegativeCash Flow
5Very Negative| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 393.13M | 108.43M | 243.76M | 598.56M | 2.43B | 2.17B |
| Gross Profit | -147.20M | -108.72M | -82.26M | -260.18M | 708.41M | 675.62M |
| EBITDA | -141.98M | -101.49M | -118.22M | -321.76M | 696.61M | 517.79M |
| Net Income | -162.31M | -239.63M | -147.80M | -344.64M | 490.50M | 324.90M |
Balance Sheet | ||||||
| Total Assets | 1.42B | 626.61M | 1.05B | 1.29B | 1.99B | 1.89B |
| Cash, Cash Equivalents and Short-Term Investments | 698.48M | 198.16M | 400.41M | 529.62M | 1.11B | 773.55M |
| Total Debt | 234.88M | 127.62M | 289.32M | 265.88M | 134.64M | 228.18M |
| Total Liabilities | 469.16M | 248.45M | 427.02M | 523.23M | 764.65M | 1.08B |
| Stockholders Equity | 948.17M | 378.31M | 618.04M | 765.84M | 1.22B | 816.21M |
Cash Flow | ||||||
| Free Cash Flow | -356.18M | -155.06M | -171.63M | -511.23M | 424.05M | 633.54M |
| Operating Cash Flow | -328.39M | -129.87M | -81.58M | -385.65M | 434.01M | 655.81M |
| Investing Cash Flow | -27.72M | -24.57M | -89.54M | -125.70M | -9.85M | -27.68M |
| Financing Cash Flow | -53.04M | -160.50M | 32.87M | -732.00K | -95.52M | -110.89M |
Jiutian Chemical Group Limited Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SG:C8R, the sentiment is Positive. The current price of 0.01 is below the 20-day moving average (MA) of 0.02, below the 50-day MA of 0.02, and below the 200-day MA of 0.02, indicating a bullish trend. The MACD of -0.00 indicates Negative momentum. The RSI at 54.27 is Neutral, neither overbought nor oversold. The STOCH value of 333.33 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SG:C8R.
Jiutian Chemical Group Limited Peers Comparison
Overall Rating
SG:QES72Outperform
SG:C0550.6Neutral
SG:M1543Neutral
SG:C8R39Underperform
SG:5WV35Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 72Outperform | SGD 558.03M | 6.98 | 9.08% | 4.70% | 4.17% | -12.40% | |
| Sector * | 61Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
| 51Neutral | SGD 35.69M | -26.40 | -0.88% | 1.06% | -7.25% | 95.72% | |
| 43Neutral | SGD 11.35M | -1.30 | -164.44% | ― | 25.81% | -30.34% | |
| 39Underperform | SGD 29.83M | -0.65 | -48.10% | ― | -69.91% | -13.56% | |
| 35Underperform | SGD 13.32M | -11.25 | -81.29% | ― | ― | ― |
* Basic Materials Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| SG:C8R | Jiutian Chemical Group Limited | 0.01 | -0.01 | -46.43% | |
| SG:QES | China Sunsine Chemical Holdings Ltd. | 0.57 | -0.09 | -13.14% | |
| SG:C05 | Chemical Industries Far East Ltd. | 0.47 | -0.05 | -9.62% | |
| SG:M15 | Matex International Limited | 0.02 | 0.00 | 0.00% | |
| SG:5DS | MegaChem Ltd. | 0.45 | 0.02 | 3.45% | |
| SG:5WV | AsiaPhos Limited | 0.01 | 0.00 | 0.00% |
Jiutian Chemical Group Limited Corporate Events
Jiutian Chemical Adjusts Board Line-Up While Keeping Governance Framework Intact
Jiutian Chemical Group Limited has announced changes in its boardroom, highlighted by the resignation of non-executive and independent director Wang Zilong effective 3 November 2026 and the appointment of new non-executive and independent director Li...
Jiutian Chemical Cleared of Liability as Arbitration Claim Withdrawn
Jiutian Chemical Group Limited has announced that an arbitration claim filed against the company at the Shanghai International Economic and Trade Arbitration Commission has been withdrawn by the claimant. The arbitral tribunal accepted the withdrawal...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Aug 25, 2026